Profile picture

Doctor Simon Frey

University Hospital Basel, Basel (Switzerland)
Membership: FESC Member EACVI Member
Follow
Biography
Simon Frey studied medicine at the University of Basel, Switzerland, where he graduated in 2014 and received his M.D. in 2015. After residency in Internal Medicine (Baden, Switzerland), he is currently specializing in non-invasive cardiology at the University Hospital Basel and King's College London/St. Thomas Hospital London. Dr. Frey participated actively in many research project in different fields of cardiology (CRT, ICD, nuclear imaging, cardiac CMR, biomarkers). His special interest lies in multimodality imaging.
Logo ESC

Contributor content

Comparison of the 2024 ESC risk-factor clinical likelihood model and an artificial intelligence-based tool for ischemia detection in patients with suspected chronic coronary syndrome referred for PET
Presentation
Comparison of the 2024 ESC risk-factor clinical likelihood model and an artificial intelligence-based tool for ischemia detection in patients with suspected chronic coronary syndrome referred for PET
Evaluation of the 2024 European Society of Cardiology risk-factor and calcium score-weighted clinical likelihoods as gatekeeper for patients with suspected chronic coronary syndrome referred for PET
Presentation
Evaluation of the 2024 European Society of Cardiology risk-factor and calcium score-weighted clinical likelihoods as gatekeeper for patients with suspected chronic coronary syndrome referred for PET
Temporal trends of normal scan results and pretest probability in myocardial perfusion imaging in a tertiary referral center in Switzerland between 2000 and 2023
Presentation
Temporal trends of normal scan results and pretest probability in myocardial perfusion imaging in a tertiary referral center in Switzerland between 2000 and 2023
The Calcium Score's power of zero in 82-Rubidium PET depending on age group and sex
Presentation
The Calcium Score's power of zero in 82-Rubidium PET depending on age group and sex
Influence of adenosine and regadenoson on left ventricular ejection fraction, myocardial blood flow and hemodynamics in vasodilator 82-Rubidium PET
Presentation
Influence of adenosine and regadenoson on left ventricular ejection fraction, myocardial blood flow and hemodynamics in vasodilator 82-Rubidium PET

ESC 365 is supported by